SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051363
Filing Date
2020-11-05
Accepted
2020-11-05 16:27:26
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10Q oric-10q_20200930.htm   iXBRL 10-Q 2956121
2 EX-31.1 oric-ex311_7.htm EX-31.1 18910
3 EX-31.2 oric-ex312_9.htm EX-31.2 18896
4 EX-32.1 oric-ex321_6.htm EX-32.1 9549
5 EX-32.2 oric-ex322_8.htm EX-32.2 9535
  Complete submission text file 0001564590-20-051363.txt   7950644

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA oric-20200930.xsd EX-101.SCH 48228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oric-20200930_cal.xml EX-101.CAL 36634
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oric-20200930_def.xml EX-101.DEF 159717
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20200930_lab.xml EX-101.LAB 370396
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20200930_pre.xml EX-101.PRE 284613
11 EXTRACTED XBRL INSTANCE DOCUMENT oric-10q_20200930_htm.xml XML 1196591
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 201290901
SIC: 2834 Pharmaceutical Preparations